Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on delivering high-quality products to improve patient care, announced today the FDA has approved a ...

FDA approval of Acetadote's simplified dosing propels Cumberland Pharmaceuticals' stock to a 90% single-day surge ...

Pharmaceuticals announced the FDA has approved a supplemental New Drug Application for its Acetadote product. Acetadote is an ...

Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company, Tuesday, announced that its supplemental New Drug ...

The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions.

Shares of Cumberland Pharmaceuticals were trading higher in the after-hours market after the company said the Food and Drug Administration approved a supplemental new drug application for liver drug ...

Analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “hold” ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a Tennessee-based specialty pharmaceutical company, saw its stock price surge by a remarkable 95.96% to $2.43 in Tuesday’s premarket trading session.

The FDA approved a supplemental NDA for Acetadote, an antidote for acetaminophen overdose indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of ...

Shares of Cumberland Pharmaceuticals (CPIX) doubled on Tuesday morning, reaching levels not seen since March 2023, following ...

Cumberland Pharmaceuticals saw shares of its stock soar nearly 100 percent in value on Tuesday following the Nashville-based ...